The emergence of blockchain networks and crypto assets is another opportunity to strike that balance. Crypto markets — and ...
Orla Mining Ltd. (TSX: OLA) (NYSE: ORLA) ("Orla" or the "Company") today announces the results for the fourth quarter and year ended December 31, 2025.
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
Revenue increased by 35.7% in 2025 to $506.8 million compared to $373.6 million in 2024. Healthcare revenue for 2025 increased to $276.5 million compared to $195.8 million in 2024, or by 41.2%.
Full year 2025 HighlightsAchieved full-year production guidance with 34,098 gold-equivalent ounces ("GEOs") produced in calendar 2025Outperformed calendar 2025 cash cost guidance with consolidated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results